Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma

Cancer Immunol Immunother. 2023 Sep;72(9):3133-3134. doi: 10.1007/s00262-023-03452-0. Epub 2023 May 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / drug therapy
  • Carcinoma, Squamous Cell* / pathology
  • Cell Line, Tumor
  • Head and Neck Neoplasms*
  • Humans
  • Mouth Neoplasms* / drug therapy
  • Mouth Neoplasms* / pathology
  • Squamous Cell Carcinoma of Head and Neck

Substances

  • naringenin